ASCENDIS PHARMA A/S: Financial statements 2012
CVR: 29918791
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
ASCENDIS PHARMA A/S (CVR 29918791) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 118,542,000 and a net result of DKK 8,938,000. The profit margin was 7.5%. Equity in the 2012 report amounted to DKK 134,644,000. The solvency ratio was 66.4%. The company had 38 employees in the financial year.
- Revenue
- DKK 118,542,000
- Gross Profit
- DKK 63,721,000
- Profit/Loss
- DKK 8,938,000
- Equity
- DKK 134,644,000
- Total Assets
- DKK 202,831,000
- Employees
- 38
Official annual report
Keep an eye on ASCENDIS PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout ASCENDIS PHARMA A/S
ASCENDIS PHARMA A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ASCENDIS PHARMA ApS and CADENZA PARTNERS ApS. The management consists of Jan Møller Mikkelsen, Anni Lotte Kirstine Pedersen and Michael Wolff Jensen. The board consists of Albert Cha (chair), Jan Møller Mikkelsen, Jean-Jacques Bienaime and Lars Holtug. The company is owned by Cede & Co. The company has 108 employees (2018). In 2025, the company reported revenue of EUR 720,132,000 and a net result of EUR -228,034,000 compared with EUR -378,084,000 the year before. Equity in the 2025 report amounted to EUR -162,821,000.